Comments on EFSA opinions on Impossible Foods’ application for EU market approval of its soy leghemoglobin product derived from GM yeast K. phaffii: Major gaps and errors identified By Claire Robinson, Co-Director, GMWatch, and Michael Antoniou, Professor of Molecular Genetics and Toxicology, King’s College London*
13 December 2024
Summary
The EFSA FAF (food additives) and GMO (genetically modified organism) Panels have issued favourable opinions on the safety of Impossible Foods’ application for EU market approval of its soy leghemoglobin product (LegH Prep) derived from a genetically modified strain of the yeast K. phaffii. The product is intended to give meat substitute products a “bleeding” appearance and a meaty flavour. Neither panel saw any safety concerns with this GM yeast derived ingredient. MORE from GMWatch.